# Safety and Efficacy of ES-NK Cell Injection in the Treatment of Refractory Lupus Nephritis: an Early Clinical Study

> **NCT07412210** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 9 (estimated)

## Conditions studied

- Systemic Lupus Erythenlatosus Nephritis

## Interventions

- **BIOLOGICAL:** AXA-NK02

## Key facts

- **NCT ID:** NCT07412210
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2029-03
- **Final completion:** 2029-03
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2026-03-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07412210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07412210, "Safety and Efficacy of ES-NK Cell Injection in the Treatment of Refractory Lupus Nephritis: an Early Clinical Study". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT07412210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*